8-K
filed February 26, 2024, 6:59 PM ET
ticker PURE
CIK 0001006028
other material
confidence high
sentiment neutral
materiality 0.15
Pure Bioscience shareholders approve increase in authorized shares to 200M
PURE BIOSCIENCE, INC.
- All six director nominees elected with 97-99% of votes cast; terms until next annual meeting.
- Ratification of Weinberg & Company as auditor for FY ending July 31, 2024 approved (99.58%).
- Non-binding advisory vote on executive compensation passed with 99.14% of votes cast.
- 2024 Equity Incentive Plan adopted with 99.17% of votes cast.
- Amendment to increase authorized common stock from 150M to 200M shares approved with 55.13% of outstanding shares.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PURE BIOSCIENCE, INC. shareholders approved Election of Directors at the 2024-02-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-02-21
Exact text from the filing
Director For Withheld Broker Non-Votes Tom Y. Lee, CPA 51,623,453 386,540 12,237,539 Ivan Chen 51,598,411 411,582 12,237,539 Tom Myers 51,643,956 366,037 12,237,539 David M. Rendall 51,637,237 372,756 12,237,539 Robert Bartlett 51,667,737 342,256 12,237,539 Bernard Blotner 50,457,923 1,552,070 12,237,539
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PURE BIOSCIENCE, INC. shareholders approved Ratification of Auditors at the 2024-02-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-02-21
Exact text from the filing
For Against Abstentions 63,801,664 268,958 176,910
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PURE BIOSCIENCE, INC. shareholders approved Amendment to Certificate of Incorporation to increase authorized shares from 150,000,000 to 200,000,000 at the 2024-02-21 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-02-21
Exact text from the filing
For Against Abstentions 61,666,543 2,226,172 314,817
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PURE BIOSCIENCE, INC. shareholders approved Adoption of the 2024 Equity Incentive Plan at the 2024-02-21 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-02-21
Exact text from the filing
For Against Abstentions Broker Non-Votes 48,041,487 401,589 3,566,917 12,237,539
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PURE BIOSCIENCE, INC. shareholders approved Executive Compensation (non-binding advisory vote) at the 2024-02-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-02-21
Exact text from the filing
For Against Abstentions Broker Non-Votes 48,049,734 412,190 3,548,069 12,237,539
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.